Primary Recipient

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS

Amount

$6,948.00

Award Date

6/15/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The rational design of a curative therapy must entail targeting the suppression of pathogenic Th2 cells. Given that both IFN-a and IFN-B are routinely used to treat hepatitis C and multiple sclerosis, our novel studies will lay the groundwork towards tes